Crowdsourced direct-to-consumer genomic analysis of a family quartet

Abstract

BackgroundWe describe the pioneering experience of a Spanish family pursuing the goal of understanding their own personal genetic data to the fullest possible extent using Direct to Consumer (DTC) tests. With full informed consent from the Corpas family, all genotype, exome and metagenome data from members of this family, are publicly available under a public domain Creative Commons 0 (CC0) license waiver. All scientists or companies analysing these data (“the Corpasome”) were invited to return results to the family.MethodsWe released 5 genotypes, 4 exomes, 1 metagenome from the Corpas family via a blog and figshare under a public domain license, inviting scientists to join the crowdsourcing efforts to analyse the genomes in return for coauthorship or acknowldgement in derived papers. Resulting analysis data were compiled via social media and direct email.ResultsHere we present the results of our investigations, combining the crowdsourced contributions and our own efforts. Four companies offering annotations for genomic variants were applied to four family exomes: BIOBASE, Ingenuity, Diploid, and GeneTalk. Starting from a common VCF file and after selecting for significant results from company reports, we find no overlap among described annotations. We additionally report on a gut microbiome analysis of a member of the Corpas family.ConclusionsThis study presents an analysis of a diverse set of tools and methods offered by four DTC companies. The striking discordance of the results mirrors previous findings with respect to DTC analysis of SNP chip data, and highlights the difficulties of using DTC data for preventive medical care. To our knowledge, the data and analysis results from our crowdsourced study represent the most comprehensive exome and analysis for a family quartet using solely DTC data generation to date.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-1973-7) contains supplementary material, which is available to authorised users.

A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults

“…Such considerations absolutely do not negate the enormous potential for applying genomics in a public health context-but they do imply that a signifi cant measure of caution should be applied as we pursue this exciting prospect. It is clear that at present we do not know how to interpret the results of genome-scale sequencing in the healthy population; our inability to reliably assign pathogenicity to variants, the tendency toward overinterpretation, misinterpretation, and our simple lack of knowledge about the natural history of most genetic disorders argue convincingly that it is premature to implement genome-scale sequencing in healthy individuals outside the realm of research [3,[37][38][39][40]. However, we do have a reasonably solid grasp of what the implications are for individuals who carry a pathogenic variation in a few of the approximately 22,000 human genes.…”

Clustering of Vibrio parahaemolyticus Isolates Using MLST and Whole-Genome Phylogenetics and Protein Motif Fingerprinting

“…Motif discovery analyses were performed on Orion Integrated Biosciences servers using MF generation (MF-gen) and CHAST algorithms to identify protein fragments associated with precise taxonomies via an exhaustive search of GenBank protein databases as described in Corpas et al (58) and Wilson et al (36). Briefly, all protein entries in GenBank were divided into 12-amino acid subsequences (motifs) that were position-independent and did not contain overlaps.…”

Accurate fetal variant calling in the presence of maternal cell contamination

“…We performed this procedure for four "real-world" trios with publicly available exome data: the Ashkenazim trio HG002_NA24385 from the Genome in the Bottle project [13] ("AJT"), the YRI_NA19240 trio from the 1000 Genomes project [14] ("YRI"), the CHD trio [15] ("CHD"), and the Corpas family daughter trio [16] ("Corpas"). Since the child in the "real-world" trios was either a living individual (AJT, YRI, Corpas) or stillborn (CHD), there was no maternal cell contamination in the "real-world" reads.…”